One of the UK’s leading development stage pharmaceutical companies, Vernalis takes promising product candidates along a commercially-focused path to market. We derive pipeline candidates both from successful collaborations with a number of global pharmaceutical businesses and our own research activities. Our pipeline reflects our strategy and is split between our later stage commercial pipeline and our NCE portfolio.
- Building a profitable and cash generative business
- Developing and commercialising low-risk late stage products for unmet medical need
- Partnering all of our drug candidates; selective investment in our in-house products
- Highly experienced executive and senior management team